Last updated 2026-08-28
- Raised $1.2M Seed round led by abC Defghij (Angel Syndicate), Feb 2024
Total raised
$1.2M
Stage
—
Founded
2023
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology
Website ↗Registrar ID: 516768207 (UTT URINE TOPICAL TREATMENT LTD)
About
UTT Urinary Tract Treatment Ltd. is an Israeli startup focused on enhancing the efficacy of bladder treatments by providing solutions for prolonged topical exposure of drugs. They are developing three proprietary technologies: a biodegradable sponge for targeted drug delivery to the bladder, a non-surgical chemo-ablation treatment (Chemo-Gel) for prostate cancer, and an in-dwelling magnetic bladder buoy (ULC) for leakage control. Their goal is to offer a paradigm change in topical drug treatments and a dignified incontinence-control device.
Funding history · 1 round · $1.2M total
1 event/round · $1.2M Total Funding: $1.2M in Private Equity
Feb 2024
★ abC Defghij (Angel Syndicate)
Offices
Tel Aviv, Israel · HQ / main office
Q&A
- What is UTT Urinary Tract Treatment Ltd.'s primary focus?
- UTT Urinary Tract Treatment Ltd. is an Israeli startup focused on enhancing the efficacy of bladder treatments by providing solutions for prolonged topical exposure of drugs for various urinary conditions.
- When was UTT Urinary Tract Treatment Ltd. founded?
- UTT Urinary Tract Treatment Ltd. was founded in 2023.
- What proprietary technologies is UTT Urinary Tract Treatment Ltd. developing?
- UTT Urinary Tract Treatment Ltd. is developing three proprietary technologies: a biodegradable sponge for targeted drug delivery to the bladder, a non-surgical chemo-ablation treatment (Chemo-Gel) for prostate cancer, and an in-dwelling magnetic bladder buoy (ULC) for leakage control.
- What are the target markets for UTT Urinary Tract Treatment Ltd.'s solutions?
- UTT Urinary Tract Treatment Ltd. targets markets including Urinary Tract Infections, Bladder Cancer, Prostate Cancer, Urinary Incontinence, Overactive Bladder, and Bladder Inflammation.
- Who is a key executive at UTT Urinary Tract Treatment Ltd.?
- Irene Zeitoun serves as the COO & Chief Research Officer at UTT Urinary Tract Treatment Ltd.
- Where is UTT Urinary Tract Treatment Ltd. headquartered?
- UTT Urinary Tract Treatment Ltd. is headquartered in Tel Aviv, Israel.
- What is the primary sector of UTT Urinary Tract Treatment Ltd.?
- UTT Urinary Tract Treatment Ltd.'s primary sector is Biotechnology.
- What is the goal of UTT Urinary Tract Treatment Ltd.?
- UTT Urinary Tract Treatment Ltd.'s goal is to offer a paradigm change in topical drug treatments and a dignified incontinence-control device.
Team · 8
Asher
Founder · Founder
Irene Zeitoun
COO & Chief Research Officer
Jaime de la Zerda
Chief Chemist
Boris Rozenblit
Analytical R&D Manager
Dr. Shira Chatumi
Director
Dr. Susan Alpert
Director
Ortal
Laboratory Manager
Ayran
Vice President of Research
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | invest.fundit.co.il/project/2340 |
|---|
Identifiers & details
| Legal name | UTT URINE TOPICAL TREATMENT LTD |
|---|---|
| Founded | 2023 |
Radar intelligence
Web history (Wayback)
| Domain | invest.fundit.co.il |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516768207 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2023-02-15 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 1 — shares_capital (1) |
| Registered address | הפלך 7 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-07-02 | הקצאת מניות |